UNIGE document Scientific Article - Case report
previous document  unige:56146  next document
add to browser collection
Title

Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin

Authors
Published in Pediatric Hematology & Oncology. 2001, vol. 18, no. 4, p. 279-82
Abstract The authors report the use of high-dose recombinant erythropoietin (r-HuEPO) in a full-term newborn baby with severe postnatal rhesus hemolytic anemia (RHA). Hemoglobin (Hb) value and reticulocyte count at day 13 of life were 59 g/L and 234 x 10(9)/L, respectively. Three days after the r-HuEPO (870 U/kg/d) administration, reticulocyte count had increased more than 4-fold and Hb rose to 73 g/L. r-HuEPO was gradually decreased after 18 days of treatment. No major side effect was observed. In selected cases of severe anemia due to hemolytic disorders, transfusions may be avoided by the use of high doses of r-HuEPO.
Keywords Anemia, Hemolytic, Congenital/drug therapy/etiologyErythropoietin/administration & dosageFemaleHemoglobins/metabolismHumansInfant, NewbornRecombinant ProteinsReticulocyte CountRh Isoimmunization/blood/complicationsTime FactorsTreatment Outcome
Identifiers
PMID: 11400653
Full text
Article (Published version) (122 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Citation
(ISO format)
WACKER, Pierre et al. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin. In: Pediatric Hematology & Oncology, 2001, vol. 18, n° 4, p. 279-82. https://archive-ouverte.unige.ch/unige:56146

131 hits

0 download

Update

Deposited on : 2015-05-13

Export document
Format :
Citation style :